hotspot -WSS

hotspot

author：hotspot 2025-10-02 10:48:41 - browse：7

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.)

The contrarian view of Viking Therapeutics

Closeup financial chart

The developer of a dual-acting GLP-1/GIP treatment for obesity is riding high on positive data and takeout speculation. The drug, called VK2735, has shown impressive weight loss with minimal gastrointestinal side effects in both subcutaneous and oral formulations, positioning it as a strong challenger to the obesity juggernauts from Eli Lilly and Novo Nordisk. With a stock price that has soared nearly 800% over the past year, Viking is now a $9 billion company and a prime acquisition target for a cash-rich pharma company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Amid AI frenzy, a top HHS official's quest to create safeguards

hotspot

WSS

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

7 people shot in DC, police say

Pfizer's Covid pill remains 89% effective in final analysis, company says

Grail is spending more than ever lobbying Congress

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Option Care buys Amedisys in $3.6 billion home care deal

focus

hotspot

The contrarian view of Viking Therapeutics

leisure time

Medicare proposal to cover medical devices draws a mixed reaction

Boston's new lab space is opening empty

Alkermes shareholders re

EPA limits use of carcinogenic gas for sterilizing medical devices

Peter Hotez and the public health issue of online harassment

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Supreme Court strikes down use of affirmative action

Change Healthcare outage fallout shows need for new oversight

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

7 people shot in DC, police say

Wikipedia

Brain 'hot spot' may explain why African Americans feel greater pain

John Green on his newest strategy for fighting tuberculosis

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Did the public have the right to know Arthur Ashe had AIDS?

Why is France rioting? What to know about the fatal police shooting of Nahel M

Pfizer's Covid pill remains 89% effective in final analysis, company says

hotspot

hotspot

focus

knowledge